In the published article there was an error in affiliation 7. Instead of “Guangdong No. 2 Provincial People’s Hospital, Guangzhou, China”, it should be “Guangdong Second Provincial General Hospital, Guangdong, China”.
In the published article, there was an error in the Funding statement. One of the funding sources was not included (Shenzhen Fundamental Research Program (JCYJ20210324140401004)). The correct Funding statement appears below.
“This work was supported by the National Key Research and Development Program of China (2017YFE0103800), the National Nature Science Foundation of China (81903371), NIMH (R34MH119963), the National Science and Technology Major Project (2018ZX10101-001-001-003), Shenzhen Fundamental Research Program (JCYJ20210324140401004), Special Found on Prevention and Control of New Coronary Pneumonia in Guangdong Universities (2020KZDZX1047), Medical Science and Technology Innovation Platform Support Project of Zhongnan Hospital, Wuhan University (PTXM2020008), the Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences (2020-PT320-004), Science and Technology Innovation Cultivation Fund of Zhongnan Hospital, Wuhan University (cxpy2017043), Medical Science Advancement Program (Basic Medical Sciences) of Wuhan University (TFJC2018004), and Discipline Cultivation Project of Department of Infectious Diseases, Zhongnan Hospital, Wuhan University (ZNXKPY2021027).”
The authors apologize for these errors and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
neutralizing antibodies, inactivated COVID-19 vaccine, people living with HIV (PLWH), seroconversion, longitudinal humoral response
Citation
Zou S, Guo W, Wu S, Ming F, Tan Y, Wu M, Tang W and Liang K (2024) Corrigendum: Six-month humoral immune response to inactivated COVID-19 vaccine among people living with HIV. Front. Immunol. 15:1494940. doi: 10.3389/fimmu.2024.1494940
Received
12 September 2024
Accepted
12 September 2024
Published
25 September 2024
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
15 - 2024
Updates
Copyright
© 2024 Zou, Guo, Wu, Ming, Tan, Wu, Tang and Liang.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Weiming Tang, Weiming_tang@med.unc.edu; Ke Liang, keliang@whu.edu.cn
†These authors have contributed equally to this work
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.